1. Ahmed M. Non-alcoholic fatty liver disease in 2015. World journal of hepatology 7, 1450–1459, doi: 10.4254/wjh.v7.i11.1450 (2015)
2. Williams C. D. et al. . Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 140, 124–131
3. Compare D. et al. Gut–liver axis: the impact of gut microbiota on non alcoholic fatty liver disease. Nutrition, metabolism, and cardiovascular diseases: NMCD 22, 471–476,
4. Horvat A., et al. Randomised clinical trial: the effects of a multispecies probiotic vs. placebo on innate immune function, bacterial translocation and gut permeability in patients with cirrhosis. Aliment Pharmacol Ther. 2016 Nov;44(9):926-935.